The approval is based on a study of the immunity of a group of children that it has already approved in October 2021. Photo: EFE / ROBERT GHEMENT

Food and Drug Administration (The FDA) To America This Tuesday, May 17, 2022, a booster dose is allowed to be used Vaccine From Pfizer / BioNTech Against Covid-19 For children ages 5 to 11.

“While it is true that Kovid-19 is generally less intense in children than in adults, its wave omicron This has made more children sick and hospitalized, “FDA Commissioner Robert M. Calliff said in a statement.

Doctors also note that some of these children may experience long-term effects, even if they do not have very serious symptoms when they become infected.

Approval is based on a Study The immune response of a group of children that has already allowed, in October 2021, approval of the full schedule use of the Pfizer vaccine for this age group.

Earlier this year, the FDA approved booster doses for young people between the ages of 12 and 15.

Covid-19 in the United States

However, children under the age of five are still not vaccinated against covid.

The country has surpassed nearly one million deaths from the coronavirus: although Johns Hopkins University maintained the number at 999,842, the U.S. government already considered that number exceeded last Thursday.

“As a nation, we should not be numb with pain. In order to heal ourselves, we must remember, “said the then President of the United States. Joe Biden.

North Korea has reported a rapid increase in infections and deaths from # covid19. State media treats patients as “people with fever” ┬╗

Someone sent something to the post office Trade On Sunday, May 15, 2022

By admin

Leave a Reply

Your email address will not be published.